SOLVENTUM CORP header image

SOLVENTUM CORP

SOLV

Equity

ISIN US83444M1018 / Valor 133635906

New York Stock Exchange, Inc (2024-11-21)
USD 69.63+1.81%

SOLVENTUM CORP
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

SOLVENTUM Corp specializes in providing chemical solvent recycling and waste management solutions for various industries.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (12.06.2024):

Q1 2024 Revenue

SOLVENTUM CORP reported a slight increase in revenue for the first quarter of 2024, with total sales reaching $2.016 billion, marking a 0.2% increase from the previous year. Organic sales growth was stronger, at 0.9%, benefiting from strategic pricing actions taken in 2023.

Q1 2024 Earnings

For the first quarter of 2024, SOLVENTUM CORP announced GAAP Earnings Per Share (EPS) of $1.37. Adjusted EPS, which excludes certain one-time costs and benefits, was higher at $2.08, reflecting operational efficiencies and effective cost management.

Q1 2024 Cash Flow

SOLVENTUM CORP generated robust cash flows in Q1 2024, with $442 million generated from operations. The company also reported a healthy free cash flow of $340 million, demonstrating strong liquidity and financial health.

Q1 2024 Profitability

The company's operating income for Q1 2024 stood at $381 million with a margin of 18.9%. Adjusted operating income was higher at $484 million, resulting in an improved margin of 24.0%, driven by higher gross profit and controlled operating expenses.

2024 Financial Outlook

SOLVENTUM CORP reaffirmed its full-year guidance for 2024, projecting organic sales growth between -2% to 0% and adjusted EPS in the range of $6.10 to $6.40. The company expects free cash flow to be between $700 million and $800 million, indicating confidence in its financial strategies and market conditions.

Summarized from source with an LLMView Source

Key figures

%1Y
%3Y
%5Y

Performance

35.5%1Y
35.5%3Y
35.5%5Y

Volatility

Market cap

12026 M

Market cap (USD)

Daily traded volume (Shares)

271,416

Daily traded volume (Shares)

1 day high/low

69.93 / 68.19

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.09%USD 37.89
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.63%CHF 91.56
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203211
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%CHF 265.80
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%CHF 75.90
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.36%CHF 108.80
Sonova Holding Ltd.
Sonova Holding Ltd. Sonova Holding Ltd. Valor: 1254978
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.20%CHF 304.00
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%CHF 210.20
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.36%CHF 0.75
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.56%CHF 108.40
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.80%CHF 61.90